OliX Pharmaceuticals Revenue

In the year 2025, OliX Pharmaceuticals had annual revenue of 14.67B KRW with 158.35% growth. OliX Pharmaceuticals had revenue of 4.53B in the quarter ending December 31, 2025, with 9,920.28% growth.

Revenue

14.67B

Revenue Growth

+158.35%

P/S Ratio

256.48

Revenue / Employee

n/a

Employees

n/a

Market Cap

3,761.70B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	14.67B	8.99B	158.35%
Dec 31, 2024	5.68B	-11.39B	-66.73%
Dec 31, 2023	17.06B	7.74B	83.09%
Dec 31, 2022	9.32B	5.65B	153.66%
Dec 31, 2021	3.67B	1.20B	48.50%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
D&D Pharmatech	4.30B
PharmaResearch	536.29B
SK bioscience	651.37B
Hugel	425.11B
Voronoi	7.51B
Peptron	5.63B
LigaChem Biosciences	141.55B
HLB Co., Ltd.	84.17B

Revenue Rankings